GoodRx (GDRX) Analyst & Key Data

Analyst Consensus

Hold9 analysts

Hold

Updated Sep 12, 2026

Total Analysts9

Buy

9

Hold

13

Sell

2

Ratings

Updated Sep 12, 2026

Overall Rating

B-

DCF Score4.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score3.0 / 5

Price / Earnings Score1.0 / 5

ROA Score3.0 / 5

ROE Score3.0 / 5

Valuation

Current Stock Price

$3.39

Median Target+8.26%

$3.67

Potential upside vs current price

DCF Value+56.62%

$5.31

Potential upside vs current price

Current Stock Price

$3.39

Median Target+8.26%

$3.67

Potential upside vs current price

DCF Value+56.62%

$5.31

Potential upside vs current price

Analyst Consensus

Hold9 analysts

Hold

Updated Sep 12, 2026

Total Analysts9

Buy

9

Hold

13

Sell

2

Ratings

Updated Sep 12, 2026

Overall Rating

B-

DCF Score4.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score3.0 / 5

Price / Earnings Score1.0 / 5

ROA Score3.0 / 5

ROE Score3.0 / 5

Valuation

Current Stock Price

$3.39

Median Target+8.26%

$3.67

Potential upside vs current price

DCF Value+56.62%

$5.31

Potential upside vs current price

Current Stock Price

$3.39

Median Target+8.26%

$3.67

Potential upside vs current price

DCF Value+56.62%

$5.31

Potential upside vs current price

GoodRx Holdings, Inc.